Pfizer Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Pfizer Ltd is ₹ 4708 as of 30 Apr 15:30 . The P/E Ratio of Pfizer Ltd is 0 as of March 2025 .The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 . The Market Cap of Pfizer Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 . The Revenue of Pfizer Ltd is ₹ 0 crore as of Mar '25 .The Revenue of Remedium Lifecare Ltd is ₹ 264.98 crore as of Mar '25 . The EBITDA of Pfizer Ltd is ₹ 0 crore as of Mar '25 .The EBITDA of Remedium Lifecare Ltd is ₹ 0.2 crore as of Mar '25 . The Net Profit of Pfizer Ltd is ₹ 0 crore as of Mar '25 .The Net Profit of Remedium Lifecare Ltd is ₹ -2.05 crore as of Mar '25 . The Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Pfizer Ltd

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Pfizer Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Pfizer Ltd or Remedium Lifecare Ltd?

Market cap of Pfizer Ltd is 21,538 Cr while Market cap of Remedium Lifecare Ltd is 40 Cr

What are the key factors driving the stock performance of Pfizer Ltd and Remedium Lifecare Ltd?

The stock performance of Pfizer Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pfizer Ltd and Remedium Lifecare Ltd?

As of May 3, 2026, the Pfizer Ltd stock price is INR ₹4708.15. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.46.

How do dividend payouts of Pfizer Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Pfizer Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.